TRACK trial on Instagram
A more visual summary of the trial and relevant context (just 6 images to look at!). Infographics by Cristina Popa
This week, we will discuss use of video aids to help with advanced care planning for dialysis and conservative kidney care in the elderly.
This week, we will discuss intermittent hemodialysis versus continuous hemodialysis for AKI in the ICU (ICRAKI study)
Day 3 : yet another IgA trial, and we are back with some flozin news: in ADPKD, their effect on hemoglobin, and on BP (with finerenone)
Day 2 was less exciting: we cover 1 IgA trial (Ravulizumab) along with another calcimimetic, and a pentoxifylline meta-analysis.
A more visual summary of the trial and relevant context (just 6 images to look at!). Infographics by Cristina Popa
Can rivaroxaban reduce cardiovascular events in advanced CKD?
The TRACK trial compared low-dose rivaroxaban with placebo in patients with stage 4–5 CKD and dialysis-dependent kidney failure at high cardiovascular risk.
Check out the latest VA and review the next #NephJC.
¿Puede rivaroxabán reducir los eventos cardiovasculares en la ERC avanzada?
El estudio TRACK comparó rivaroxabán a dosis bajas frente a placebo en pacientes con ERC estadio 4–5 y enfermedad renal en diálisis con alto riesgo cardiovascular.
Revisa nuestro más reciente resumen visual y acompáñanos en la próxima discusión de #NephJC.